This drug could help millions keep their kidneys working longer

An international study found that finerenone slows kidney function decline and reduces the risk of serious kidney and cardiovascular complications in people with chronic kidney disease who do not have diabetes. The results could open the door to a much-needed new treatment option for the majority of CKD patients who have long had limited choices.

This story was reported by Healthy Aging News -- ScienceDaily. EUROPES curates Europe's most relevant coverage — read the full report at the original source.